Cardiovascular disease risk in childhood cancer survivors

American Journal of Epidemiology

Volumn 180, Issue 1, 2014, Pages 120-123

  Olsen, Morten ^a   Schmidt, Morten ^a   Lash, Timothy Lee ^b   Sørensen, Keld ^a   Pedersen, Lars ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CARDIOVASCULAR DISEASE; CHILD HEALTH; EPIDEMIOLOGY; HEALTH RISK; RISK ASSESSMENT; SURVIVAL;

ARTICLE; BONE TUMOR; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILD; CHILDHOOD CANCER; CONGESTIVE HEART FAILURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEPATOBLASTOMA; HUMAN; ICD-10; ICD-8; ISCHEMIC HEART DISEASE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NERVOUS SYSTEM TUMOR; OUTCOME ASSESSMENT; PERICARDITIS; RETINOBLASTOMA; SUBARACHNOID HEMORRHAGE; TESTIS CANCER; VALVULAR HEART DISEASE; VENOUS THROMBOEMBOLISM;

DENMARK;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SURVIVORS;

EID: 84903941184     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu144     Document Type: Article

References (26)

1. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-1582.
2. Lipshultz SE, Landy DC, Lopez-Mitnik G, et al. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol. 2012; 30(10):1050-1057.
3. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.
4. Mueller S, Fullerton HJ, Stratton K, et al. Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013;86(4):649-655.
5. Mueller S, Sear K, Hills NK, et al. Risk of first and recurrent stroke in childhood cancer survivors treated with cranial and cervical radiation therapy. Int J Radiat Oncol Biol Phys. 2013; 86(4):643-648.
6. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24(33):5277-5282.
7. Kero AE, Järvelä LS, Arola M, et al. Cardiovascular morbidity in long-term survivors of early-onset cancer: a population-based study. Int J Cancer. 2014;134(3):664-673.
8. van der Pal HJ, van Dalen EC, van Delden E, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol. 2012;30(13):1429-1437.
9. Wogelius P, Skriver MV, Sørensen HT. Predictive value of childhood cancer diagnoses in the Danish Cancer Registry. J Pediatr Hematol Oncol. 2004;26(11):701-702.
10. Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. 1997;44(5):535-539.
11. Birch JM, Marsden HB. A classification scheme for childhood cancer. Int J Cancer. 1987;40(5):620-624.
12. Li J, Cnattingus S, Gissler M, et al. The 5-minute Apgar score as a predictor of childhood cancer: a population-based cohort study in five million children. BMJ Open. 2012;2(4).
13. Pedersen CB, Gøtzsche H, Møller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449.
14. Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484-3488.
15. Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics. 2008;121(2): e387-e396.
16. Lip GYH, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):27-34.
17. Erichsen R, Christiansen CF, Mehnert F, et al. Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case-control study. Intern Emerg Med. 2012;7(5):431-438.
18. Guzzetti S, Costantino G, Sada S, et al. Colorectal cancer and atrial fibrillation: a case-control study. Am J Med. 2002;112(7): 587-588.
19. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6): 695-706.
20. Partap S. Stroke and cerebrovascular complications in childhood cancer survivors. Semin Pediatr Neurol. 2012;19(1): 18-24.
21. Sørensen K, Levitt GA, Bull C, et al. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer. 2003;97(8):1991-1998.
22. Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer. 2000;88(4): 672-678.
23. Andersen TF, Madsen M, Jørgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3): 263-268.
24. Krarup LH, Boysen G, Janjua H, et al. Validity of stroke diagnoses in a national register of patients. Neuroepidemiology. 2007;28(3):150-154.
25. Madsen M, Davidsen M, Rasmussen S, et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2): 124-130.
26. Nuver J, Smit AJ, Postma A, et al. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev. 2002;28(4): 195-214.